Selected research
Industry Research
Medical Device Software Validation Industry Research Report 2026
Market perspective
The global Medical Device Software Validation market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Medical Device Software Validation market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Medical Device Software Validation market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Medical Device Software Validation market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Medical Device Software Validation include QbD Group, Intertek, SGS, QuEST, TÜV SÜD AG, NAMSA, Element, Eurofins Scientific and Charles River, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Medical Device Software Validation market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Medical Device Software Validation.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Medical Device Software Validation Market by Company
QbD Group
Intertek
SGS
QuEST
TÜV SÜD AG
NAMSA
Element
Eurofins Scientific
Charles River
Sterling Medical Devices
Pacific Biolabs
Toxikon
Steris Laboratories
Europlaz Technologies
Tata Elxsi
Onyx Healthcare
Medical Device Software Validation Segment by Type
Unit Testing
Integration Testing
System Testing
Others
Medical Device Software Validation Segment by Application
Medical Device Manufacturing
Pharmaceutical
Biotechnology
Research and Development
Medical Device Software Validation Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Device Software Validation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Device Software Validation and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Device Software Validation.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Medical Device Software Validation companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Unit Testing
- Integration Testing
- System Testing
- Others
Applications
- Medical Device Manufacturing
- Pharmaceutical
- Biotechnology
- Research and Development
Companies covered
- QbD Group
- Intertek
- SGS
- QuEST
- TÜV SÜD AG
- NAMSA
- Element
- Eurofins Scientific
- Charles River
- Sterling Medical Devices
- Pacific Biolabs
- Toxikon
- Steris Laboratories
- Europlaz Technologies
- Tata Elxsi
- Onyx Healthcare
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Medical Device Software Validation by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Unit Testing
- 2.2.3 Integration Testing
- 2.2.4 System Testing
- 2.2.5 Others
- 2.3 Medical Device Software Validation by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Medical Device Manufacturing
- 2.3.3 Pharmaceutical
- 2.3.4 Biotechnology
- 2.3.5 Research and Development
- 2.4 Assumptions and Limitations
3 Medical Device Software Validation Breakdown Data by Type
- 3.1 Global Medical Device Software Validation Historic Market Size by Type (2021-2026)
- 3.2 Global Medical Device Software Validation Forecasted Market Size by Type (2027-2032)
4 Medical Device Software Validation Breakdown Data by Application
- 4.1 Global Medical Device Software Validation Historic Market Size by Application (2021-2026)
- 4.2 Global Medical Device Software Validation Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Medical Device Software Validation Market Perspective (2021-2032)
- 5.2 Global Medical Device Software Validation Growth Trends by Region
- 5.2.1 Global Medical Device Software Validation Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Medical Device Software Validation Historic Market Size by Region (2021-2026)
- 5.2.3 Medical Device Software Validation Forecasted Market Size by Region (2027-2032)
- 5.3 Medical Device Software Validation Market Dynamics
- 5.3.1 Medical Device Software Validation Industry Trends
- 5.3.2 Medical Device Software Validation Market Drivers
- 5.3.3 Medical Device Software Validation Market Challenges
- 5.3.4 Medical Device Software Validation Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Medical Device Software Validation Players by Revenue
- 6.1.1 Global Top Medical Device Software Validation Players by Revenue (2021-2026)
- 6.1.2 Global Medical Device Software Validation Revenue Market Share by Players (2021-2026)
- 6.2 Global Medical Device Software Validation Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Medical Device Software Validation Head Office and Area Served
- 6.4 Global Medical Device Software Validation Players, Product Type & Application
- 6.5 Global Medical Device Software Validation Manufacturers Established Date
- 6.6 Global Medical Device Software Validation Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Medical Device Software Validation Market Size (2021-2032)
- 7.2 North America Medical Device Software Validation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Medical Device Software Validation Market Size by Country (2021-2026)
- 7.4 North America Medical Device Software Validation Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Medical Device Software Validation Market Size (2021-2032)
- 8.2 Europe Medical Device Software Validation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Medical Device Software Validation Market Size by Country (2021-2026)
- 8.4 Europe Medical Device Software Validation Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Medical Device Software Validation Market Size (2021-2032)
- 9.2 Asia-Pacific Medical Device Software Validation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Medical Device Software Validation Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Medical Device Software Validation Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Medical Device Software Validation Market Size (2021-2032)
- 10.2 South America Medical Device Software Validation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Medical Device Software Validation Market Size by Country (2021-2026)
- 10.4 South America Medical Device Software Validation Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Medical Device Software Validation Market Size (2021-2032)
- 11.2 Middle East & Africa Medical Device Software Validation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Medical Device Software Validation Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Medical Device Software Validation Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 QbD Group
- 12.1.1 QbD Group Company Information
- 12.1.2 QbD Group Business Overview
- 12.1.3 QbD Group Revenue in Medical Device Software Validation Business (2021-2026)
- 12.1.4 QbD Group Medical Device Software Validation Product Portfolio
- 12.1.5 QbD Group Recent Developments
- 12.2 Intertek
- 12.2.1 Intertek Company Information
- 12.2.2 Intertek Business Overview
- 12.2.3 Intertek Revenue in Medical Device Software Validation Business (2021-2026)
- 12.2.4 Intertek Medical Device Software Validation Product Portfolio
- 12.2.5 Intertek Recent Developments
- 12.3 SGS
- 12.3.1 SGS Company Information
- 12.3.2 SGS Business Overview
- 12.3.3 SGS Revenue in Medical Device Software Validation Business (2021-2026)
- 12.3.4 SGS Medical Device Software Validation Product Portfolio
- 12.3.5 SGS Recent Developments
- 12.4 QuEST
- 12.4.1 QuEST Company Information
- 12.4.2 QuEST Business Overview
- 12.4.3 QuEST Revenue in Medical Device Software Validation Business (2021-2026)
- 12.4.4 QuEST Medical Device Software Validation Product Portfolio
- 12.4.5 QuEST Recent Developments
- 12.5 TÜV SÜD AG
- 12.5.1 TÜV SÜD AG Company Information
- 12.5.2 TÜV SÜD AG Business Overview
- 12.5.3 TÜV SÜD AG Revenue in Medical Device Software Validation Business (2021-2026)
- 12.5.4 TÜV SÜD AG Medical Device Software Validation Product Portfolio
- 12.5.5 TÜV SÜD AG Recent Developments
- 12.6 NAMSA
- 12.6.1 NAMSA Company Information
- 12.6.2 NAMSA Business Overview
- 12.6.3 NAMSA Revenue in Medical Device Software Validation Business (2021-2026)
- 12.6.4 NAMSA Medical Device Software Validation Product Portfolio
- 12.6.5 NAMSA Recent Developments
- 12.7 Element
- 12.7.1 Element Company Information
- 12.7.2 Element Business Overview
- 12.7.3 Element Revenue in Medical Device Software Validation Business (2021-2026)
- 12.7.4 Element Medical Device Software Validation Product Portfolio
- 12.7.5 Element Recent Developments
- 12.8 Eurofins Scientific
- 12.8.1 Eurofins Scientific Company Information
- 12.8.2 Eurofins Scientific Business Overview
- 12.8.3 Eurofins Scientific Revenue in Medical Device Software Validation Business (2021-2026)
- 12.8.4 Eurofins Scientific Medical Device Software Validation Product Portfolio
- 12.8.5 Eurofins Scientific Recent Developments
- 12.9 Charles River
- 12.9.1 Charles River Company Information
- 12.9.2 Charles River Business Overview
- 12.9.3 Charles River Revenue in Medical Device Software Validation Business (2021-2026)
- 12.9.4 Charles River Medical Device Software Validation Product Portfolio
- 12.9.5 Charles River Recent Developments
- 12.10 Sterling Medical Devices
- 12.10.1 Sterling Medical Devices Company Information
- 12.10.2 Sterling Medical Devices Business Overview
- 12.10.3 Sterling Medical Devices Revenue in Medical Device Software Validation Business (2021-2026)
- 12.10.4 Sterling Medical Devices Medical Device Software Validation Product Portfolio
- 12.10.5 Sterling Medical Devices Recent Developments
- 12.11 Pacific Biolabs
- 12.11.1 Pacific Biolabs Company Information
- 12.11.2 Pacific Biolabs Business Overview
- 12.11.3 Pacific Biolabs Revenue in Medical Device Software Validation Business (2021-2026)
- 12.11.4 Pacific Biolabs Medical Device Software Validation Product Portfolio
- 12.11.5 Pacific Biolabs Recent Developments
- 12.12 Toxikon
- 12.12.1 Toxikon Company Information
- 12.12.2 Toxikon Business Overview
- 12.12.3 Toxikon Revenue in Medical Device Software Validation Business (2021-2026)
- 12.12.4 Toxikon Medical Device Software Validation Product Portfolio
- 12.12.5 Toxikon Recent Developments
- 12.13 Steris Laboratories
- 12.13.1 Steris Laboratories Company Information
- 12.13.2 Steris Laboratories Business Overview
- 12.13.3 Steris Laboratories Revenue in Medical Device Software Validation Business (2021-2026)
- 12.13.4 Steris Laboratories Medical Device Software Validation Product Portfolio
- 12.13.5 Steris Laboratories Recent Developments
- 12.14 Europlaz Technologies
- 12.14.1 Europlaz Technologies Company Information
- 12.14.2 Europlaz Technologies Business Overview
- 12.14.3 Europlaz Technologies Revenue in Medical Device Software Validation Business (2021-2026)
- 12.14.4 Europlaz Technologies Medical Device Software Validation Product Portfolio
- 12.14.5 Europlaz Technologies Recent Developments
- 12.15 Tata Elxsi
- 12.15.1 Tata Elxsi Company Information
- 12.15.2 Tata Elxsi Business Overview
- 12.15.3 Tata Elxsi Revenue in Medical Device Software Validation Business (2021-2026)
- 12.15.4 Tata Elxsi Medical Device Software Validation Product Portfolio
- 12.15.5 Tata Elxsi Recent Developments
- 12.16 Onyx Healthcare
- 12.16.1 Onyx Healthcare Company Information
- 12.16.2 Onyx Healthcare Business Overview
- 12.16.3 Onyx Healthcare Revenue in Medical Device Software Validation Business (2021-2026)
- 12.16.4 Onyx Healthcare Medical Device Software Validation Product Portfolio
- 12.16.5 Onyx Healthcare Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst